OBJECTIVES The aim of this study was to examine temporal trends in the incidence and outcomes of heart failure (HF) complicating acute myocardial infarction (AMI) in a large national cohort.
H eart failure (HF) is a major health problem worldwide (1, 2) . It carries a poor prognosis (5-year cumulative mortality of 40% to 50%) (1) and requires frequent readmissions to the hospital (35% to 50% within 6 months). Coronary heart disease and hypertension constitute the major underlying causes of HF. Both pre-existing chronic HF and the development of de novo HF as a complication of acute myocardial infarction (AMI) are associated with worsened short-and long-term outcome (3) (4) (5) . The prognosis of patients after AMI has markedly improved during the past 15 to 20 years, and mortality rates from coronary heart disease in Intensive Care Admissions) registry, the aim of this study was to describe the incidence, temporal trends, and prognostic significance of inhospital post-AMI HF over a time period of 13 years.
METHODS T HE SWED E HE A R T/ R IK S-H IA R E GI ST R Y.
The RIKS-HIA database was established as a national quality registry in 1995 and today includes all Swedish hospitals that provide acute coronary care (n ¼ 72).
The registry enrolls consecutive patients admitted to coronary care units because of symptoms suggestive of acute coronary syndromes. Information is collected prospectively for more than 100 variables, including baseline characteristics, electrocardiographic findings, examinations, interventions, inhospital complications, discharge medications, and diagnoses. The whole process has been described elsewhere (14, 15) . Desta et al.
In-Hospital HF Complicating AMI and Outcomes years). The proportion of women in the study population also increased modestly (from 35.0% to 37.1%). The use at discharge of aspirin, clopidogrel, betablockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers continuously increased over the study period, aspirin from 81.7% to 90.3%, clopidogrel from <5% to 80%, beta-blockers from 75.0% to 86.5%, angiotensinconverting enzyme inhibitors or angiotensin II receptor blockers from 36.9% to 68.1%, and statins from 21.5% to 80.6% ( Table 1) .
MORTALITY. The estimated in-hospital (Figure 1) , 30-day, and 1-year mortality for patients with clinical HF and AMIs decreased over the years from 19% to 13%, from 23% to 17%, and from 36% to 31%, respectively (p < 0.001, chi-square test for trend). 2,9,10,12,13,20,21) . This is the largest observational study examining temporal trends in the incidence Chi-square test for trend: p < 0.001. AMI ¼ acute myocardial infarction; HF ¼ heart failure. Log-rank p < 0.001. AMI ¼ acute myocardial infarction; HF ¼ heart failure. It is worth noting that although men still constitute the majority of the HF group, the proportion of women progressively increased throughout the study period. We also observed an increasing proportion of HF with normal EF, which might partly reflect the increasing proportion of women with comorbidities such as hypertension.
Given the sheer size of our study population and robust data with a high degree of validity, as well as a long period of follow-up, it is likely that our findings reflect a prevailing reality. However, this contradicts the claims of a few previous studies that reported an increased incidence of post-myocardial infarction HF (2,9,12). Ezekowitz et al. (2) reported an increasing incidence of in-hospital HF after a first AMI by 25% among elderly patients from 1994 to 2000. In contrast, we saw a declining incidence across all age categories. The earlier investigators included patients managed in the primary health care system as well as in hospitals, whereas our study included only hospitalized patients with AMIs, which might have contributed to the differences in our findings. 
